UFP Technologies, Inc.
UFPTHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeUFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. Valued at $2.29B, UFPT is a mid-cap name in its sector. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Market Cap
$2.29B
Beta
1.03
P/E (TTM)
31.94
P/E (Fwd)
24.91
EPS (TTM)
$9.26
EPS (Fwd)
$11.87
ROE
17.1%
ROA
9.1%
Cash
$9.0M
Total Debt
$136.3M
Free CF
$34.9M
52W Change
47.9%
Annual Financials
Cash vs Debt
Where UFPT stands vs its 150-day and 200-day moving averages
As of the October 14, 2026 close, UFPT finished 18.95% above its 150-day moving average ($247.40) and 19.57% above its 200-day moving average ($246.12). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is UFPT overbought or oversold?
At the October 14, 2026 close, UFPT's RSI(14) was 55.3, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, UFPT has $9.0M in cash with $136.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $34.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 17.1% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $353.8M (2022) to $602.8M (2025), reflecting a 70% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for UFP Technologies, Inc. and its sector.